Twist Bioscience (TWST) Receivables - Other (2018 - 2026)

Twist Bioscience (TWST) has reported Receivables - Other for 8 consecutive years, with $17.1 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Receivables - Other changed N/A year-over-year to $17.1 million; the TTM figure through Mar 2026 stood at $17.1 million (changed N/A YoY), while the FY2025 annual figure was $290000.0, changed N/A from the prior year.
• Receivables - Other climbed to $17.1 million in Q1 2026 per TWST's latest filing, from $290000.0 in the prior quarter.
• Across five years, Receivables - Other topped out at $17.1 million in Q1 2026 and bottomed at $290000.0 in Q3 2025.
• Historically, Receivables - Other has averaged $6.2 million across 4 years, with a median of $5.3 million in 2022.
• Annual changes were most pronounced in 2022 — Receivables - Other jumped 107.17% — and 2023, when it declined 16.39%.
• Twist Bioscience's Receivables - Other stood at $5.3 million in 2022, then increased by 6.0% to $5.6 million in 2023, then sank by 94.79% to $290000.0 in 2025, then surged by 5796.55% to $17.1 million in 2026.
• Business Quant data shows TWST's Receivables - Other at $17.1 million in Q1 2026, $290000.0 in Q3 2025, and $5.6 million in Q2 2023.